Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion.
Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion.
Several local firms are looking to enter new markets and create alliances, mainly in the areas of generics and biotechnology.
As a result, the last editions of the CPhI (Convention on Pharmaceutical Ingredients) in Barcelona had a marked Argentine accent. Some firms were there as visitors, while others, including Bagó; Biosidus; the Chemo group, Jorge Braver with his firm BCN Peptides, Dromex, and Eriochem, had their own stands.
Executives from Amega Biotech, including ex CEO Francisco Molinari, and new general manager Federico Rivera were also active in the corridors at the event.
[tribulant_slideshow gallery_id=»257″]
